65 results on '"Wu, Yuehui"'
Search Results
2. Stochastic Single-Allocation Hub Location Routing Problem for the Design of Intra-City Express Systems
3. Alterations in brain network functional connectivity and topological properties in DRE patients
4. Crude Steel Production and Procurement Joint Decision Modeling Under the National Regulation of Production and Emissions Limitation
5. Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)
6. Branch-and-price-and-cut algorithm for the capacitated single allocation hub location routeing problem
7. Intracerebral Hemorrhage Imaging Based on Hybrid Deep Learning With Electrical Impedance Tomography
8. A Sample Average Approximation Approach for the Stochastic Dial-A-Ride Problem on a Multigraph with User Satisfaction
9. Adaptive large neighborhood decomposition search algorithm for multi-allocation hub location routing problem
10. Urban heat vulnerability: A dynamic assessment using multi-source data in coastal metropolis of Southeast China
11. Trajectory optimization for connected and automated vehicles in a drop-off area of the departure curbside
12. Chronobiological Patterns of Aneurysmal Subarachnoid Hemorrhage in Central China
13. Residual Convolutional Neural Network-Based Stroke Classification With Electrical Impedance Tomography
14. Image Reconstruction of Conductivity Distribution With Combined L 1-Norm Fidelity and Hybrid Total Variation Penalty
15. Profitable Pickup and Delivery Problem with Time Windows and Compatibility Constraints
16. Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I / II open‐label, dose escalation study
17. Arrangement of boundary electrodes for detection of frontal lobe disease with electrical impedance tomography
18. Non-Coding RNAs as Circulating Biomarkers for the Diagnosis of Intracranial Aneurysm: A Systematic Review and Meta-Analysis
19. The Role of Aspirin in the Management of Intracranial Aneurysms: A Systematic Review and Meta-Analyses
20. Letter to the Editor Regarding “Association Between Aspirin Use and Risk of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis”
21. Letter by Wu and Yu Regarding Article, “Smoking Causes Fatal Subarachnoid Hemorrhage: A Case-Control Study of Finnish Twins”
22. Sparse image reconstruction of intracerebral hemorrhage with electrical impedance tomography
23. Letter regarding article ‘Abdominal aortic aneurysm is associated with subarachnoid hemorrhage’
24. Kinesin Family Member C1 Increases Temozolomide Resistance of Glioblastoma Through Promoting DNA Damage Repair
25. A new surgical method of treatment spontaneous intracranial hemorrhage
26. Dose Finding Experiments: Responses of Mixed Type
27. A Non-Convex L₁-Norm Penalty-Based Total Generalized Variation Model for Reconstruction of Conductivity Distribution
28. BET inhibitor molibresib for the treatment of advanced solid tumors: Final results from an open-label phase I/II study.
29. Open-Label Pilot Study of Genetically Engineered NY-ESO-1 Specific T Cells (GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma
30. Generalized Probit Model in Design of Dose Finding Experiments
31. Open-Label Pilot Study of Genetically Engineered NY-ESO-1 Specific T Cells (GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma
32. Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
33. Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC
34. Abstract CT225: A Phase Ib/IIa randomized pilot study to investigate the safety and tolerability of autologous T-cells with enhanced T-cell receptors specific to NY-ESO-1/LAGE-1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer
35. Abstract CT225: A Phase Ib/IIa randomized pilot study to investigate the safety and tolerability of autologous T-cells with enhanced T-cell receptors specific to NY-ESO-1/LAGE-1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer
36. Stereotactic aspiration for hypertensive intracerebral haemorrhage in a Chinese population: a retrospective cohort study
37. Network Planning Location Model for China Railway Express
38. Abstract CT104: A first-in-human phase I dose escalation study of BET inhibitor GSK2820151 in patients with advanced or recurrent solid tumors cancers
39. A phase I/II dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with fulvestrant in subjects with ER+ breast cancer.
40. A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer
41. MicroRNA-130b promotes cell migration and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma
42. Effects of Business Knowledge on Competences of Business English Teachers in Local Universities and Colleges - Taking Yunnan Province as an Example
43. Abstract CT014: GSK525762, a selective bromodomain (BRD) and extra terminal protein (BET) inhibitor: results from part 1 of a phase I/II open-label single-agent study in patients with NUT midline carcinoma (NMC) and other cancers
44. Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib inRAS-mutant relapsed or refractory myeloid malignancies
45. ATPase inhibitory factor 1 is a potential prognostic marker for the migration and invasion of glioma
46. Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC).
47. Abstract CT205: A phase I dose-escalation study of trametinib (T) in combination with continuous or intermittent GSK2126458 (GSK458) in patients (pts) with advanced solid tumors
48. Efficacy and tolerability in an open-label phase I/II study of MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in combination in patients (pts) with BRAF V600E mutated colorectal cancer (CRC).
49. Comparative study on the efficiency and environmental impact of two methods of utilizing polyvinyl chloride waste based on life cycle assessments
50. Oral MEK1/MEK2 inhibitor trametinib (GSK1120212) in combination with docetaxel in KRAS-mutant and wild-type (WT) advanced non-small cell lung cancer (NSCLC): A phase I/Ib trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.